Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Gottex Management’s portable alpha equity strategy gains 39% in 2013

Tuesday, January 28, 2014

Komfie Manalo, Opalesque Asia:

Independent global alternative asset management group Gottex Fund Management Holdings Limited said that its key products generated positive returns for 2013 with its portable alpha S&P500 equity strategy gaining 39% for the year. The Penjing Asian strategy added 16%, while the alternative credit strategy posted a return of 8.5%. Both core market neutral strategies generated performance fees in the second half of 2013.

Gottex Chairman and CEO, Joachim Gottschalk commented, "We are very excited by the proposed merger with the EIM Group, which we believe will establish a platform for growth of the company. The combination of both firms will deepen and broaden our investment capabilities and enhance our global footprint. It increases our talent pool in all areas, which will allow us to offer enhanced investment and advisory solutions to existing and future clients."

Highlights of Gottex’s quarterly report showed:

  • Total fee-earning assets for the group were USD 5.3 billion compared to USD 5.8 billion at 30 September 2013, as a result of limited net outflows.
  • In recent weeks Gottex launched the Gottex Endowment Strategy Fund, a daily multi-asset mutual fund in the US, as well as a daily multi-asset UCITS fund in Europe, both in close co-operation with large platform partners.
  • The proposed merger (subject to approval of regulatory authorities and Gottex shareholders) betw......................

    To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner